£247.00

Genomics-Driven Drug Discovery Through Pharmacogenomics

Pharmacology

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£247 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price

Price Analysis

Most common price: £247 (73 days, 100.0%)

Price range: £247 - £247

Price levels: 1 different prices over 73 days

Description

Genetic diseases and disorders are common factors in modern pharmacogenomics. The study of emerging factors in epigenomics are significant for effective drug discovery and formulation, as well as for balancing pharmacological and ethical factors in drug development. The goal of drug discovery is to recognize the new molecular formulations impactful in the treatment of genetic diseases. Further exploration of the move from preclinical drug research to the clinical stage may reveal critical transformations to provide effective medicinal products in the market. As precision medicine evolves, genomics-driven drug discovery may also improve patient outcomes while reducing the trial-and-error approach to prescribing medications, assisting with individualized, targeted healthcare. Genomics-Driven Drug Discovery Through Pharmacogenomics explores the integration of genomics into drug discovery and development in the pharmacogenomics field. It offers effective solutions to address challenges of personalized healthcare, ethical dilemmas, and technological considerations involved in drug discovery. This book covers topics such as medical technology, personalized medicine, and drug development, and is a useful resource for medical professionals, healthcare workers, computer engineers, scientists, pharmacologists, academicians, and researchers.

Product Specifications

Format: hardcover
ASIN: B0DQQWTVZ7
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 13 December 2024
Listed Since: 17 December 2024

Barcode

No barcode data available

Genomics-Driven Drug Discovery Through Pharmacogenomics

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Multidisciplinary Applications of Natural Science for Drug Discovery and Integrative Medicine

Modern Spectroscopic Techniques for Drug Discovery and Environmental Sustainability

Molecular Modeling and Docking Techniques for Drug Discovery and Design

Technological Approaches to Medical and Pharmaceutical Education

Isolation, Characterization, and Therapeutic Applications of Natural Bioactive Compounds

AI-Enabled Smart Healthcare Using Biomedical Signals (Advances in Bioinformatics and Biomedical Engineering)

Embracing Transhumanism and Genomics in Human Resources Management

Driving Global Health and Sustainable Development Goals With Smart Technology

AI-Driven Personalized Healthcare Solutions

Bridging Technology and Development for Sustainable Innovation and Geopolitical Dynamics

Pharmacological Benefits of Natural Agents (Advances in Medical Diagnosis, Treatment, and Care)

Driving Quality Education Through AI and Data Science

Financial Digital Assets and the Financial Risk Modeling of Portfolio Investments

Natural Products as Cancer Therapeutics

Revolutionizing Education With Remote Experimentation and Learning Analytics

Emerging Technologies for Health Literacy and Medical Practice

AI-Driven Healthcare Cybersecurity and Privacy

AI-Powered Systems for Healthcare Diagnostics and Treatment

AI-Driven Breakthroughs in Antimicrobial Resistance

Data Analytics and AI for Quantitative Risk Assessment and Financial Computation

Revolutionizing Urban Development and Governance With Emerging Technologies

Bioethics of Displacement and Its Implications

Multidisciplinary Educational Perspectives on Design-Based Research

Implications of Nanoecotoxicology on Environmental Sustainability